BRIEF published on 05/11/2026 at 09:05, 2 months 23 days ago Nynomic AG Sees Positive Q1 Results, Upgrades Outlook Order Backlog Nynomic AG Q1 Results Semiconductor Growth NyFIT2025
PRESS RELEASE published on 05/11/2026 at 09:00, 2 months 23 days ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG, formerly NuWays AG, shows positive Q1 results with sales growth and EBIT turning positive. Impressive order backlog and margin trajectory. LayTec and other subsidiaries contribute to growth. Analyst increases PT to EUR 25 Nynomic AG Q1 Results PT Increase Positive Growth LayTec
BRIEF published on 03/25/2026 at 09:05, 4 months 9 days ago Nynomic AG's Path to Recovery and Growth in 2026 Profitable Growth Nynomic AG FY25 Financials LayTec Semiconductor Tools
PRESS RELEASE published on 03/25/2026 at 09:00, 4 months 9 days ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG FY25 prelims show signs of recovery with group revenues at €92.6m. FY26 guidance expects sales growth and higher profit margins. LayTec niche in InP semiconductor crucial for future growth Sales Growth Profitable Growth Nynomic AG FY26 Guidance LayTec FY25 Prelims InP Semiconductor
BRIEF published on 11/07/2025 at 09:06, 8 months 26 days ago Nynomic AG Shows Signs of Recovery Amid Challenging Conditions Financial Guidance Order Intake Q3 Results Nynomic AG Efficiency Program
PRESS RELEASE published on 11/07/2025 at 09:01, 8 months 26 days ago Original-Research: Nynomic AG (von NuWays AG): Buy Nynomic AG's Q3 preliminary results show signs of recovery, with improved order intake and positive EBIT. Sales guidance lowered for FY25, but positive outlook with efficiency program EBIT Order Intake Q3 Results Nynomic AG Efficiency Program
BRIEF published on 08/14/2025 at 09:05, 11 months 20 days ago Nynomic AG Faces Challenges Amid Restructuring and Weak Demand Restructuring Mid-term Prospects Revenue Decline Nynomic AG NyFIT2025
PRESS RELEASE published on 08/14/2025 at 09:00, 11 months 20 days ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG research update: Q2 revenue down 13%, weak demand. Forecast adjustment, efficiency program NyFIT2025, and lowered price target. BUY recommendation maintained Research Update Price Target Nynomic AG Efficiency Program Q2 Revenue
BRIEF published on 05/09/2025 at 09:06, 1 year 2 months ago Nynomic AG: A Challenging Start to 2025 Amid Market Uncertainty Order Backlog Financial Outlook Nynomic AG Semiconductor Market Market Uncertainty
PRESS RELEASE published on 05/09/2025 at 09:01, 1 year 2 months ago Original-Research: Nynomic AG (von NuWays AG): BUY Nynomic AG (DE000A0MSN11) research update: Preliminary Q1 results show sales decline, but management expects gradual improvements throughout FY25. Reaffirmed mid-term targets and BUY rating BUY Rating Research Update Sales Decline Nynomic AG Mid-term Targets
Published on 08/03/2026 at 23:00, 1 hour 56 minutes ago Viemed Healthcare Announces Second Quarter 2026 Financial Results
Published on 08/01/2026 at 01:20, 2 days 23 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 2 days 23 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 3 days ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 08/03/2026 at 23:33, 1 hour 23 minutes ago EQS-Adhoc: Verbio SE: Preliminary EBITDA for FY 2025/2026 exceeds forecast
Published on 08/03/2026 at 23:20, 1 hour 36 minutes ago DeFi Technologies Announces Shareholder Call to Discuss Q2 2026 Financial Results
Published on 08/03/2026 at 21:39, 3 hours 17 minutes ago PAUL Tech AG reports net income after tax of EUR 3.2 million for fiscal year 2025 and issues a positive outlook for fiscal year 2026
Published on 08/03/2026 at 19:35, 5 hours 21 minutes ago Enzene Launches NeX™, a Comprehensive Suite of Solutionsto Enable Cost-Efficient, High-Yielding Local Biomanufacturing
Published on 08/03/2026 at 19:01, 5 hours 55 minutes ago EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026
Published on 08/03/2026 at 18:45, 6 hours 11 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 08/03/2026 at 17:45, 7 hours 11 minutes ago Monthly disclosure of the total number of shares and voting rights - July 2026
Published on 08/03/2026 at 17:40, 7 hours 16 minutes ago Eiffage announces the end of exclusive negotiations with Atlas Arteria for the possible acquisition of the Warnow Tunnel concession in Rostock, Germany
